{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:39:22Z","timestamp":1784677162435,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Major depression is the second leading cause of years lost to disability worldwide and is a leading contributor to suicide. However, first-line antidepressants are only fully effective for 33%, and only 40% of those offered psychological treatment attend for two sessions or more. Views gained from patients and primary care professionals are that greater treatment uptake might be achieved if people with depression could be offered alternative and more accessible treatment options. Although there is evidence that the Alpha-Stim Anxiety Insomnia and Depression (AID) device is safe and effective for anxiety and depression symptoms in people with anxiety disorders, there is much less evidence of efficacy in major depression without anxiety. This study investigates the effectiveness of the Alpha-Stim AID device, a cranial electrotherapy stimulation (CES) treatment that people can safely use independently at home. The device provides CES which has been shown to increase alpha oscillatory brain activity, associated with relaxation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The aim of this study is to investigate the clinical and cost-effectiveness of Alpha-Stim AID in treatment-seeking patients (aged 16 years upwards) with moderate to moderately severe depressive symptoms in primary care. The study is a multi-centre parallel-group, double-blind, non-commercial, randomised controlled superiority trial. The primary objective of the study is to examine the clinical efficacy of active daily use of 8 weeks of Alpha-Stim AID versus sham Alpha-Stim AID on depression symptoms at 16 weeks (8 weeks after the end of treatment) in people with moderate severity depression. The primary outcome is the 17-item Hamilton Depression Rating Scale at 16 weeks. All trial and treatment procedures are carried out remotely using videoconferencing, telephone and postal delivery considering the COVID-19 pandemic restrictions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study is investigating whether participants using the Alpha-Stim AID device display a reduction in depressive symptoms that can be maintained over 8 weeks post-treatment. The findings will help to determine whether Alpha-Stim AID should be recommended, including being made available in the NHS for patients with depressive symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ISRTCN <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.isrctn.com\/ISRCTN11853110?q=&amp;filters=conditionCategory:Mental%20and%20Behavioural%20Disorders&amp;sort=&amp;offset=1&amp;totalResults=2528&amp;page=1&amp;pageSize=10&amp;searchType=basicsearch\">ISRCTN11853110<\/jats:ext-link>. Registered on 14 August 2020<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06192-1","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T10:04:17Z","timestamp":1649066657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A randomised controlled trial investigating the clinical and cost-effectiveness of Alpha-Stim AID cranial electrotherapy stimulation (CES) in patients seeking treatment for moderate severity depression in primary care (Alpha-Stim-D Trial)"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5537-0717","authenticated-orcid":false,"given":"Shireen","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Boutry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Craven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boliang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Smart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Higton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"McNaughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Briley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Sayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Morriss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"issue":"9859","key":"6192_CR1","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England). 2012;380(9859):2163\u201396.","journal-title":"Lancet (London, England)"},{"key":"6192_CR2","volume-title":"Leed","author":"S McManus","year":"2016","unstructured":"McManus S, Bebbington PE, Jenkins R, Brugha T. Mental health and wellbeing in England: the Adult Psychiatric Morbidity Survey 2014. In: McManus S, Bebbington P, Jenkins R, Brugha T, editors. Leed. UK: NHS Digital; 2016."},{"key":"6192_CR3","unstructured":"NICE England. The NHS Long Term Plan.\u00a02019.\u00a0Available from: https:\/\/www.longtermplan.nhs.uk\/. Accessed 12 Aug 2021."},{"key":"6192_CR4","volume-title":"NHS digital","author":"T Vizard","year":"2020","unstructured":"Vizard T, Sadler K, Ford T, Newlove-Delgado T, McManus S, Marcheselli F. Mental health of children and young people in England, 2020: wave 1 follow up to the 2017 survey. In: NHS digital; 2020. https:\/\/files.digital.nhs.uk\/CB\/C41981\/mhcyp_2020_rep.pdf. Accessed 12 Aug 2020."},{"key":"6192_CR5","unstructured":"Office for National Statistics: Coronavirus and depression in adults, Great Britain: July to August 2021.\u00a02021. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/wellbeing\/articles\/coronavirusanddepressioninadultsgreatbritain\/latest. Accessed 12 Aug 2021."},{"key":"6192_CR6","unstructured":"NICE: Depression in adults: recognition and management.\u00a02009. https:\/\/www.nice.org.uk\/guidance\/cg90. Accessed 12 Aug 2021."},{"key":"6192_CR7","unstructured":"National Health Service Digital: Psychological Therapies, Annual report on the use of IAPT services 2019-20.\u00a02020. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/psychological-therapies-annual-reports-on-the-use-of-iapt-services\/annual-report-2019-20. Accessed 12 Aug 2021."},{"issue":"2","key":"6192_CR8","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1016\/S2468-2667(20)30288-7","volume":"6","author":"MJ Carr","year":"2021","unstructured":"Carr MJ, Steeg S, Webb RT, Kapur N, Chew-Graham CA, Abel KM, et al. Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: a population-based cohort study. Lancet Public Health. 2021;6(2):e124\u2013e35. https:\/\/doi.org\/10.1016\/S2468-2667(20)30288-7.","journal-title":"Lancet Public Health."},{"issue":"1","key":"6192_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12875-021-01496-8","volume":"22","author":"R Ashcroft","year":"2021","unstructured":"Ashcroft R, Donnelly C, Dancey M, Gill S, Lam S, Kourgiantakis T, et al. Primary care teams\u2019 experiences of delivering mental health care during the COVID-19 pandemic: a qualitative study. BMC Fam Pract. 2021;22(1):143. https:\/\/doi.org\/10.1186\/s12875-021-01496-8.","journal-title":"BMC Fam Pract."},{"issue":"2","key":"6192_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jneumeth.2013.07.016","volume":"219","author":"B Guleyupoglu","year":"2013","unstructured":"Guleyupoglu B, Schestatsky P, Edwards D, Fregni F, Bikson M. Classification of methods in transcranial electrical stimulation (TES) and evolving strategy from historical approaches to contemporary innovations. J Neurosci Methods. 2013;219(2):297\u2013311. https:\/\/doi.org\/10.1016\/j.jneumeth.2013.07.016.","journal-title":"J Neurosci Methods."},{"issue":"8","key":"6192_CR11","first-page":"112","volume":"2","author":"R Kennerly","year":"2004","unstructured":"Kennerly R. QEEG analysis of cranial electrotherapy: a pilot study. J Neurother. 2004;2(8):112\u20133. Presented at the International Society for Neuronal Regulation Annual Conference","journal-title":"J Neurother"},{"key":"6192_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.healthplace.2017.01.001","volume":"44","author":"B Klijs","year":"2017","unstructured":"Klijs B, Mendes de Leon CF, EUB K, Smidt N. Do social relations buffer the effect of neighborhood deprivation on health-related quality of life? Results from the LifeLines Cohort Study. Health Place. 2017;44:43\u201351.","journal-title":"Health Place"},{"issue":"6","key":"6192_CR13","doi-asserted-by":"publisher","first-page":"414","DOI":"10.7326\/M17-1970","volume":"168","author":"PG Shekelle","year":"2018","unstructured":"Shekelle PG, Cook IA, Miake-Lye IM, Booth MS, Beroes JM, Mak S. Benefits and harms of cranial electrical stimulation for chronic painful conditions, depression, anxiety, and insomnia: a systematic review. Ann Intern Med. 2018;168(6):414\u201321. https:\/\/doi.org\/10.7326\/M17-1970.","journal-title":"Ann Intern Med."},{"issue":"3","key":"6192_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.4088\/JCP.v69n0311","volume":"69","author":"A Bystritsky","year":"2008","unstructured":"Bystritsky A, Kerwin L, Feusner J. A pilot study of cranial electrotherapy stimulation for generalized anxiety disorder. J Clin Psychiatry. 2008;69(3):412\u20137. https:\/\/doi.org\/10.4088\/JCP.v69n0311.","journal-title":"J Clin Psychiatry."},{"key":"6192_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jad.2014.04.029","volume":"164","author":"TH Barclay","year":"2014","unstructured":"Barclay TH, Barclay RD. A clinical trial of cranial electrotherapy stimulation for anxiety and comorbid depression. J Affect Disord. 2014;164:171\u20137. https:\/\/doi.org\/10.1016\/j.jad.2014.04.029.","journal-title":"J Affect Disord."},{"key":"6192_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jad.2019.04.020","volume":"253","author":"R Morriss","year":"2019","unstructured":"Morriss R, Xydopoulos G, Craven M, Price L, Fordham R. Clinical effectiveness and cost minimisation model of Alpha-Stim cranial electrotherapy stimulation in treatment seeking patients with moderate to severe generalised anxiety disorder. J Affect Disord. 2019;253:426\u201337. https:\/\/doi.org\/10.1016\/j.jad.2019.04.020.","journal-title":"J Affect Disord."},{"issue":"6","key":"6192_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1037\/ccp0000654","volume":"89","author":"M Ciharova","year":"2021","unstructured":"Ciharova M, Furukawa TA, Efthimiou O, Karyotaki E, Miguel C, Noma H, et al. Cognitive restructuring, behavioral activation and cognitive-behavioral therapy in the treatment of adult depression: a network meta-analysis. J Consult Clin Psychol. 2021;89(6):563\u201374. https:\/\/doi.org\/10.1037\/ccp0000654.","journal-title":"J Consult Clin Psychol."},{"key":"6192_CR18","unstructured":"NICE: Alpha-Stim AID for anxiety disorders.\u00a02021. https:\/\/www.nice.org.uk\/guidance\/mtg56. Accessed 17 Dec 2021."},{"issue":"3","key":"6192_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/YIC.0b013e3282f948f5","volume":"23","author":"JB Williams","year":"2008","unstructured":"Williams JB, Kobak KA, Bech P, Engelhardt N, Evans K, Lipsitz J, et al. The GRID-HAMD: standardization of the Hamilton Depression Rating Scale. Int Clin Psychopharmacol. 2008;23(3):120\u20139. https:\/\/doi.org\/10.1097\/YIC.0b013e3282f948f5.","journal-title":"Int Clin Psychopharmacol."},{"key":"6192_CR20","first-page":"200","volume":"2","author":"J Beecham","year":"2001","unstructured":"Beecham J, Knapp M. Costing psychiatric interventions. Meas Mental Health Needs. 2001;2:200\u201324.","journal-title":"Meas Mental Health Needs."},{"issue":"10","key":"6192_CR21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"9","key":"6192_CR22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med."},{"issue":"10","key":"6192_CR23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Internal Med. 2006;166(10):1092\u20137. https:\/\/doi.org\/10.1001\/archinte.166.10.1092.","journal-title":"Arch Internal Med."},{"issue":"5","key":"6192_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1192\/bjp.180.5.461","volume":"180","author":"JC Mundt","year":"2002","unstructured":"Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180(5):461\u20134. https:\/\/doi.org\/10.1192\/bjp.180.5.461.","journal-title":"Br J Psychiatry."},{"key":"6192_CR25","unstructured":"First MB, Williams JB, Karg RS, Spitzer RL. User\u2019s guide for the SCID-5-CV structured clinical interview for DSM-5\u00ae disorders: clinical version.\u00a0Arlington: American Psychiatric Publishing, Inc; 2016."},{"issue":"4","key":"6192_CR26","first-page":"203","volume":"19","author":"C Yixin","year":"2007","unstructured":"Yixin C, Lin Y, Jiuping Z, Lejia L, Tunong C, Yi C. Results of cranial electrotherapy stimulation to children with mixed anxiety and depressive disorder. Shanghai Arch Psychiatry. 2007;19(4):203\u20135.","journal-title":"Shanghai Arch Psychiatry."},{"issue":"22","key":"6192_CR27","doi-asserted-by":"publisher","first-page":"i","DOI":"10.3310\/hta13220","volume":"13","author":"T Kendrick","year":"2009","unstructured":"Kendrick T, Chatwin J, Dowrick C, Tylee A, Morriss R, Peveler R, et al. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study. Health Technol Assess. 2009;13(22):i\u2013182.","journal-title":"Health Technol Assess"},{"issue":"5","key":"6192_CR28","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.jval.2010.12.004","volume":"14","author":"SA Gerhards","year":"2011","unstructured":"Gerhards SA, Huibers MJ, Theunissen KA, de Graaf LE, Widdershoven GA, Evers SM. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD). Value Health. 2011;14(5):732\u20139. https:\/\/doi.org\/10.1016\/j.jval.2010.12.004.","journal-title":"Value Health"},{"key":"6192_CR29","unstructured":"NICE: Position statement on use of the EQ-5D-5L valuation set for England.\u00a02019. https:\/\/www.nice.org.uk\/about\/what-we-do\/our-programmes\/nice-guidance\/technology-appraisal-guidance\/eq-5d-5l. Accessed 12 Aug 2020."},{"issue":"2","key":"6192_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jval.2015.02.001","volume":"18","author":"SD Ramsey","year":"2015","unstructured":"Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, et al. Cost-effectiveness analysis alongside clinical trials II\u2014an ISPOR Good Research Practices Task Force Report. Value in Health. 2015;18(2):161\u201372. https:\/\/doi.org\/10.1016\/j.jval.2015.02.001.","journal-title":"Value in Health."},{"issue":"2","key":"6192_CR31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/bimj.201300188","volume":"56","author":"M O\u2019Kelly","year":"2014","unstructured":"O\u2019Kelly M. Multiple imputation and its application. James Carpenter and Michael Kenward (2013). Chichester: John Wiley & Sons. 345 pages, ISBN: 9780470740521. Biom J. 2014;56(2):352\u20133. https:\/\/doi.org\/10.1002\/bimj.201300188.","journal-title":"Biom J."},{"key":"6192_CR32","doi-asserted-by":"publisher","unstructured":"Carpenter JR, Goldstein H, Kenward MG. REALCOM-IMPUTE software for multilevel multiple imputation with mixed response types. 2011;45(5):14. https:\/\/doi.org\/10.18637\/jss.v045.i05.","DOI":"10.18637\/jss.v045.i05"},{"issue":"5","key":"6192_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1192\/bjp.bp.116.195867","volume":"211","author":"C Henderson","year":"2017","unstructured":"Henderson C, Robinson E, Evans-Lacko S, Thornicroft G. Relationships between anti-stigma programme awareness, disclosure comfort and intended help-seeking regarding a mental health problem. Br J Psychiatry. 2017;211(5):316\u201322. https:\/\/doi.org\/10.1192\/bjp.bp.116.195867.","journal-title":"Br J Psychiatry."},{"key":"6192_CR34","doi-asserted-by":"publisher","first-page":"l1508","DOI":"10.1136\/bmj.l1508","volume":"364","author":"G Iacobucci","year":"2019","unstructured":"Iacobucci G. NHS prescribed record number of antidepressants last year. BMJ. 2019;364:l1508. https:\/\/doi.org\/10.1136\/bmj.l1508.","journal-title":"BMJ."},{"issue":"1","key":"6192_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12916-019-1253-5","volume":"17","author":"R Morriss","year":"2019","unstructured":"Morriss R, Patel S, Malins S, Guo B, Higton F, James M, et al. Clinical and economic outcomes of remotely delivered cognitive behaviour therapy versus treatment as usual for repeat unscheduled care users with severe health anxiety: a multicentre randomised controlled trial. BMC Med. 2019;17(1):16. https:\/\/doi.org\/10.1186\/s12916-019-1253-5.","journal-title":"BMC Med."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06192-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06192-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06192-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T10:07:05Z","timestamp":1649066825000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06192-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6192"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06192-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,4]]},"assertion":[{"value":"11 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial received REC and HRA approval from East Midlands - Leicester South Research Ethics Committee (REC Reference: \/EM\/0061). We currently have obtained site approvals for East Midlands and Thames Valley and South Midlands (TVSM) Primary Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"Electromedical Products International, Inc. will manufacture the devices, and the Microcurrent Site Ltd. will distribute the devices. However, both companies will play no part in the delivery, analysis or interpretation of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"250"}}